Safety and Efficacy of a Novel Skin Lightening Agent for Melasma

June 2017 in “ Journal of The American Academy of Dermatology ”

SM04554 topical treatment male androgenetic alopecia AGA Norwood-Hamilton classifications hair follicle counts hair follicles Ki-67 hair bulb hair growth follicle formation male pattern baldness

TLDR The new treatment was safe and may effectively treat male pattern hair loss.

The document detailed a phase 2 clinical trial that assessed the safety and effectiveness of SM04554, a topical treatment for male androgenetic alopecia (AGA). The trial involved 49 male participants with Norwood-Hamilton classifications of 4-6, who were treated daily for 90 days with either 0.15% or 0.25% SM04554, or a placebo. Results indicated that the 0.25% SM04554 group had a significant increase in total hair follicle counts and various types of hair follicles at Days 91 and 135 compared to the placebo. The 0.15% group also showed significant improvements at Day 135. Additionally, an increase in Ki-67 in the hair bulb was observed, which is indicative of hair growth and/or follicle formation. The study concluded that SM04554 was safe, well-tolerated, and potentially effective for treating AGA. The research was sponsored by Samumed LLC.

View this study on jaad.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 8 results

community First patient dosed with Pyrilutamide (Kintor) Phase III

in Research/Science 200 upvotes 2 years ago

First patient dosed with Pyrilutamide (Kintor) Phase III for hair loss treatment. Pyrilutamide differs from approved treatments as it competes with DHT to bind hair follicles, potentially reducing side effects.

community 2020 Hair and Scalp Treatments: A Clinical Guide (in Depth 350 Page Guide)

in Treatment 64 upvotes 4 years ago

Treatments for hair loss, including topical immunotherapy, regenerative treatments, laser and light-based therapies, oral supplements, intralesional steroids, and new drugs like finasteride and minoxidil.

community Reminder that Kintors Pyrilutamide results will be out this month

in Treatment 181 upvotes 3 years ago

Kintor's Pyrilutamide results for hair loss treatment will be released soon. The treatment may replace current treatments like finasteride and minoxidil without systemic side effects.

community Sensitive to Oral fin + RU. Am I screwed?

in Product 6 upvotes 3 years ago

Akinfenrawr experienced negative side effects from oral finasteride and RU58841, and is seeking alternative hair loss treatments. They discuss various options, including raloxifene, oral dutasteride, liposomal finasteride, Breezula, Pyrilutamide, SM04554, and sulforaphane, but have concerns about efficacy, availability, and cost.

community Anyone here holding out for Breezula?

in Treatment 6 upvotes 4 years ago

The conversation is about individuals considering waiting for Breezula to treat hair loss instead of using Finasteride due to concerns about side effects. Some are opting for Finasteride now, while others are wary of its impact on neurosteroids.

community When will Breezula, SM04554, Follica FOL-004, follicum FOL-005 arrive in Canada?

in Question 8 upvotes 4 years ago

The conversation is about the availability of hair loss treatments Breezula, SM04554, Follica FOL-004, and Follicum FOL-005 in Canada after FDA approval, including potential delays, loopholes for obtaining them, and insurance coverage.

Related Research

1 / 1 results

research Safety and Efficacy of a Novel Skin Lightening Agent for Melasma

June 2017 in “Journal of The American Academy of Dermatology”

The new treatment was safe and may effectively treat male pattern hair loss.